ERH knockdown blocks the cell cycle procession in the G2/M phase (8); this is especially obvious in human Kirsten rat sarcoma viral oncogene homolog (KRAS) mutation-related tumors (such as colorectal, lung and pancreatic cancer) (9). Here, KRAS is linked to pancreatic neoplasm.